News | Radiation Oncology | July 07, 2015

New Texas Proton Center Selects RayStation for Treatment Planning

Opening in late 2015, the 63,0000-square-foot facility will feature three treatment rooms with capacity to treat more than 100 patients daily

RaySearch, RayStation, Texas Center for Proton Therapy, treatment planning

July 7, 2015 - The Texas Center for Proton Therapy announced it has selected RayStation from RaySearch Laboratories as its treatment planning software. The 63,000-square-foot facility in the Dallas/Fort Worth area will have capacity to treat more than 100 patients per day in three treatment rooms when it opens in late 2015. It will be the first stand-alone LEED-Certified (Leadership in Energy and Environmental Design) proton therapy center in the United States. 

"It is our goal to provide advanced technologies such as robust optimization, PBS [pencil beam scanning], IMPT [intensity modulated proton therapy] and full adaptive therapy, right from the start of clinical operations. We believe that RaySearch has a proven track record that can help us deliver on the promise of developing treatment plans with the best technology available today in proton therapy," said Andrew Lee, M.D., medical director of the center.  "We will also utilize the wide area network available at the local Texas Oncology facilities so that we can share information and develop the best plans available for the patients. We can compare conventional photon plans with proton plans and choose the right course of action," he concluded.

Lee joins Texas Center for Proton Therapy following almost 14 years at The University of Texas MD Anderson Cancer Center. He also served as the first and founding director of the Program for Advanced Technology, and as the medical director of the MD Anderson Proton Therapy Center.

The current version of RayStation supports all relevant proton treatment techniques such as uniform scanning, double scattering and PBS/IMPT. It also features unique functionalities like multi-criteria optimization (MCO) for PBS optimization. MCO planning makes it possible to plan in a more interactive and exploratory way where fundamental trade-offs can be made in real time by the dosimetrist and the physician. It can help simplify the planning process while improving the quality of the plans.

The Texas Center for Proton Therapy is a collaboration of Texas Oncology and The U.S. Oncology Network, supported by McKesson Specialty Health and Baylor Health Enterprises, an affiliate of Baylor Health Care System.

For more information:

Related Content

Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
MedLever Showcases Radiation Oncology Applications at ASTRO 2017
News | Radiation Therapy | October 05, 2017
MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability,...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Overlay Init